Search results
Reliance Industries: 'Show me' story RIL can add $100 bn value, says Morgan Stanley as it shares...
Business Today· 4 days agoRIL shares: Morgan Stanley said monetisation cycles have delivered 2-3 times value creation for RIL...
RIL shares can create up to $100 billion wealth, predicts Morgan Stanley
The Economic Times· 4 days agoMukesh Ambani-led Reliance Industries' (RIL) fourth monetisation cycle can create a $60-100 billion...
Reliance Industries shares have potential to create up to $100 billion wealth - Morgan Stanley’s big...
The Times of India· 4 days agoThe firm believes that RIL's fourth monetisation cycle has the potential to increase its market...
Reliance Industries share price rises more than 20% year to date: Morgan Stanley expects more gains...
Livemint· 3 days agoStock Market today: Reliance Industries share price that remains in focus following telecom price...
RIL's market capitalisation to swell by up to $100 billion, predicts Morgan Stanley
CNBC Awaaz· 3 days agoOver the past three decades, RIL has delivered 2-3x returns for shareholders, with each decade...
RIL can add up to $100 billion in market cap: Morgan Stanley
Financial Express· 4 days agoIn the last nearly 3 decades, RIL has delivered 2-3x value creation for shareholders, with each...
Bajaj Allianz Life launches Nifty Alpha 50 Index Fund: Check details
Business Standard India· 2 days agoThe NFO aims to provide capital appreciation by investing in equities that are part of the Nifty...
Stars are aligning! Vodafone Idea share price targets increase after tariff hike
The Economic Times· 4 days agoThe retail favourite stock has already rallied around 23% in the last one month and now Citi has...
Vraj Iron hits upper circuit after listing at 16% premium over issue price
Business Standard India· 2 days agoVraj Iron and Steel listed at Rs 240 apiece on both the BSE and NSE, marking a premium of 15.94 per...
Pharma shares shine; Dr Reddy's, FDC, Glenmark, Suven trade at record highs
Business Standard India· 2 days agoShares of pharmaceutical companies were in focus, and rallied up to 12 per cent on the BSE in...